tiprankstipranks
BioMarin Pharmaceutical (IT:1BMRN)
:1BMRN
Italy Market

BioMarin Pharmaceutical (1BMRN) Technical Analysis

1 Followers

Summary of all the Indicators

Overall Consensus
Neutral
7Bullish
0Neutral
6Bearish
Technical Analysis Consensus
Strong Buy
1Bullish
0Neutral
0Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
BioMarin Pharmaceutical’s (1BMRN) Moving Averages Convergence Divergence (MACD) indicator is 0.81, suggesting BioMarin Pharmaceutical is a Buy.
BioMarin Pharmaceutical’s (1BMRN) 20-Day exponential moving average is 52.12, while BioMarin Pharmaceutical’s (1BMRN) share price is €54.46, making it a Sell.
BioMarin Pharmaceutical’s (1BMRN) 50-Day exponential moving average is 50.60, while BioMarin Pharmaceutical’s (1BMRN) share price is €54.46, making it a Buy.

BioMarin Pharmaceutical (1BMRN) Pivot Points

Aug 02, 2026, 05:46 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
Fibonacci
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

BioMarin Pharmaceutical (1BMRN) Moving Averages

Aug 02, 2026, 05:46 PM
Period
Simple
Exponential
MA5
53.34Sell
52.69Sell
MA10
52.63Sell
52.63Sell
MA20
52.25Sell
52.12Sell
MA50
50.12Buy
50.60Buy
MA100
48.53Buy
49.54Buy
MA200
48.43Buy
48.90Buy
BioMarin Pharmaceutical’s (1BMRN) 10-Day exponential moving average is 52.63, while BioMarin Pharmaceutical’s (1BMRN) share price is €54.46, making it a Sell.
BioMarin Pharmaceutical’s (1BMRN) 100-Day exponential moving average is 49.54, while BioMarin Pharmaceutical’s (1BMRN) share price is €54.46, making it a Buy.
BioMarin Pharmaceutical’s (1BMRN) stock price is €54.46 and BioMarin Pharmaceutical’s (1BMRN) 50-day simple moving average is 50.12, creating a Buy signal.
BioMarin Pharmaceutical’s (1BMRN) stock price is €54.46 and BioMarin Pharmaceutical’s (1BMRN) 100-day simple moving average is 48.53, creating a Buy signal.
BioMarin Pharmaceutical’s (1BMRN) stock price is €54.46 and BioMarin Pharmaceutical’s (1BMRN) 200-day simple moving average is 48.43, creating a Buy signal.

BioMarin Pharmaceutical (1BMRN) Technical Indicators

Aug 02, 2026, 05:46 PM
Name
Value
Implied Action
RSI (14)
56.24
Neutral
STOCH (9,6)
55.27
Neutral
STOCHRSI (14)
55.27
Neutral
MACD (12,26)
0.81
Buy
ADX (14)
20.75
Neutral
Williams %R
-53.90
Buy
CCI (14)
52.00
Neutral
ATR (14)
1.18
-
Ultimate Oscillator
32.18
Neutral
ROC
0.31
Buy
BioMarin Pharmaceutical’s (1BMRN) Relative Strength Index (RSI) is 56.24, creating a Neutral signal.
BioMarin Pharmaceutical’s (1BMRN) Trend Strength Indicator (ADX) is 20.75, creating a Neutral signal.
BioMarin Pharmaceutical’s (1BMRN) Commodity Channel Index (CCI) is 52.00, creating a Neutral signal.
BioMarin Pharmaceutical’s (1BMRN) Price Rate of Change (ROC) is 0.31, creating a Buy signal.

FAQ

Is 1BMRN a Buy, Hold, or Sell?
Based on 1BMRN’s technical indicators, 1BMRN is a Hold.
    What is 1BMRN’s RSI (14)?
    1BMRN’s RSI (14) is 56.24, which suggests 1BMRN is a Neutral.
      What is 1BMRN’s MACD?
      1BMRN’s MACD is 0.81, which suggests 1BMRN is a Buy.
        What is 1BMRN’s 5-day moving average?
        1BMRN’s 5-day moving average is 53.34, which suggests 1BMRN is a Sell.
          What is 1BMRN’s 20-day moving average?
          1BMRN 20-day moving average is 52.25, which suggests 1BMRN is a Sell.
            What is 1BMRN’s 50-day moving average?
            1BMRN’s 50-day moving average is 50.12, which suggests 1BMRN is a Buy.
              What is 1BMRN’s 200-day moving average?
              1BMRN’s 200-day moving average is 48.43, which suggests 1BMRN is a Buy.
                What is 1BMRN’s Williams % R (14)?
                1BMRN’s Williams % R (14) is -53.90, which suggests 1BMRN is a Buy.
                  What is 1BMRN’s CCI (14)?
                  1BMRN’s CCI (14) is 52.00, which suggests 1BMRN is a Neutral.
                    What is the share price of BioMarin Pharmaceutical?